级联酶催化支持饥饿和光动力学协同治疗乳腺癌
Baoqing Liu1, Xu Huang1, Xiandong Shi1
1College of Life Sciences, Nanjing Normal University, Nanjing 210023, China.
Biological & pharmaceutical bulletin
|June 26, 2025
概括
这项研究介绍了一种新的纳米平台,将饥饿疗法 (ST) 和乳腺癌光动力疗法 (PDT) 结合起来. 该系统使用酶来增强治疗效果和氧气水平,显示出改善的抗瘤疗效.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 缺氧限制了光动力学治疗 (PDT) 在瘤中的有效性.
- 结合饥饿疗法 (ST) 和PDT等疗法可以改善抗癌结果.
- 开发有针对性的纳米载体对于有效的药物输送和协同疗法至关重要.
研究的目的:
- 设计和开发一个纳米平台,用于协同治疗乳腺癌.
- 使用级联酶酶反应系统集成ST和PDT.
- 为了克服PDT中缺氧诱导的限制,并提高抗瘤功效.
主要方法:
- 使用加酸 (CaP) 纳米粒子装载着绿色氨酸 (ICG) 构建了一个纳米平台.
- 在CaP上联合固定的葡萄糖氧化酶 (GOX) 和催化酶 (CAT),封装在藻酸盐 (SA) 中.
- 评估了生物相容性,瘤积累,溶酶体降解和协同抗瘤作用在体外和体内.
主要成果:
- 该ICG/CaP@GOX-CAT@SA纳米系统显示出优异的生物相容性和瘤特异性积累.
- GOX通过消耗葡萄糖来启动ST,而CAT将H2O2转化为O2,缓解瘤缺氧.
- 级联酶系统协同增强了ST和PDT,导致显著的抗瘤疗效.
结论:
- 开发的纳米平台通过级联酶反应有效地集成ST和PDT.
- 该系统成功地克服了瘤缺氧,提高了治疗结果.
- 这种方法为协同组合性癌症治疗提供了一个有希望的策略.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.8K
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.7K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
